Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Vascular Medicine
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Sieveking, D. P
Right arrow Articles by Ng, M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sieveking, D. P
Right arrow Articles by Ng, M. K.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

review-article

Cell therapies for therapeutic angiogenesis: back to the bench

Daniel P Sieveking

Heart Research Institute and ; Department of Medicine, University of Sydney

Martin KC Ng

Heart Research Institute and ; Department of Medicine, University of Sydney; Royal Prince Alfred Hospital mkcng{at}med.usyd.edu.au

Abstract

The discovery, over a decade ago, of endothelial progenitor cells that are able to participate in neovascularization of adult tissue has been greeted enthusiastically because of the potential for new cell-based therapies for therapeutic angiogenesis. Since that time, an ever-growing list of candidate cells has been proposed for cardiovascular regeneration. However, to date, pre-clinical and clinical studies evaluating the therapeutic potential of various cell therapies have reported conflicting results, generating controversy. Key issues within the field of cell therapy research include a lack of uniform cellular definitions, as well as inadequate functional characterization of the role of putative stem/progenitor cells in angiogenesis. Given the mixed results of initial clinical studies, there is now a scientific imperative to understand better the vascular biology of candidate cells in order to better translate cell therapy to the bedside. This review will provide a translationally relevant overview of the biology of candidate stem/progenitor cells for therapeutic angiogenesis.

Key Words: angiogenesis • cardiovascular diseases • cells • clinical trials • cultured • endothelial cells

Vascular Medicine, Vol. 14, No. 2, 153-166 (2009)
DOI: 10.1177/1358863X08098698
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 JEMHome page
D. P. Sieveking, P. Lim, R. W.Y. Chow, L. L. Dunn, S. Bao, K. C.Y. McGrath, A. K. Heather, D. J. Handelsman, D. S. Celermajer, and M. K.C. Ng
A sex-specific role for androgens in angiogenesis
J. Exp. Med., January 18, 2010; (2010) jem.20091924v2.
[Abstract] [Full Text]

Home page
 Eur Heart JHome page
S. Garg, H. J. Duckers, and P. W. Serruys
Endothelial progenitor cell capture stents: will this technology find its niche in contemporary practice?
Eur. Heart J., January 10, 2010; (2010) ehp591v1.
[Full Text] [PDF]